News Summary:
On August 18, 2026, Veqta highlighted the critical role of accurate informed consent translation as a strategic differentiator for sponsors and CROs in global studies, emphasizing its importance for patient safety, data integrity, and regulatory compliance with agencies such as the FDA, EMA, and PMDA. The company also noted the necessity of navigating Arabic dialects effectively for US-based organizations operating across the Middle East and North Africa to avoid derailing projects due to miscommunication. Earlier the same day, Veqta underscored that medical French translation quality presents a clinical risk issue for hospitals, CROs, and device manufacturers, particularly when source texts are dense, ambiguous, or evolving. Further, it discussed how effective Polish interpretation is crucial for international events to foster genuine debate during high-stakes briefings, investor roadshows, and regulatory hearings. Previously, on August 16, Veqta detailed that quality in Czech document translation projects extends beyond grammar, focusing on mitigating risks like semantic drift, mistranslated regulatory concepts, and inconsistent terminology for legal, financial, and technical teams.
Subscribe for full access to Veqta's products in full detail 
